Schedule 13G ownership disclosure
Tarsus Pharmaceuticals Inc
Security class unavailable · CUSIP: 87650L103
Event date: Unavailable
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 2,097,323
- Percent of class
- 5.5100%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000932471-24-000741
- Form type
- SC 13G
- Filer
- Tarsus Pharmaceuticals, Inc.
- CIK
- CIK 1819790
- Filed
- Nov 04, 2024
- Reporting period
- —
- Description
- Schedule 13G beneficial ownership